NUTRA PHARMA CORP
AI Executive Summary
AI-powered analysis of 10-Q filing content
Nutra Pharma Corp shows severe financial distress with stockholders' deficit of $16.4M, critically low cash of $3,603 (90% decline), and current liabilities exceeding current assets by over 31x. Total liabilities of $17.1M dramatically outweigh assets of $710K, indicating potential insolvency.
Red Flags Detected (8)
Cash declined 90% from $36,447 to $3,603 - critical liquidity crisis
Stockholders' deficit of $16.35M indicates technical insolvency
Current ratio of 0.032 (liabilities exceed assets 31x)
5 more red flags detected
Key Takeaways
Company appears technically insolvent with liabilities exceeding assets by 24x
Extreme liquidity crisis with less than $4K cash remaining
2 more takeaways
Filing Overview
What This Means
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.